Approximately 80 percent of patients who have the hepatitis C virus may have been missed through EMR-reliant risk-based testing, according to research from the CDC. The paper, published in Clinical ...

For stable, symptomatic patients with suspected CAD who are deemed to be at “minimal risk” using a CT-based tool, deferral of diagnostic testing is just as safe as the usual approach and is even ...

Using Federal, State, and Grassroots Advocacy to Effect Change in Cancer Care Delivery and Patient Outcomes in the United States This manuscript addresses the current landscape and highlights upcoming ...

As infectious disease physicians who believe strongly in the safety and effectiveness of vaccination, we have been advocating for risk-based COVID-19 vaccine recommendations for years. At the recent ...

AI-enabled risk stratification tool for TB progression targeted for late 2027 launch, designed to support all QuantiFERON customers with informed clinical decision-making for patient care QIAGEN and ...